Drug
Epi 743
Epi 743: highest development phase Phase 2, developed by PTC Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| EPI-743 NCT02352896 | Phase 2 | Leigh Syndrome |
Latest
No recent events.
Follow Epi 743 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.